Nukkleus (NASDAQ:NUKK) Stock Price Up 8.7% – Still a Buy?

Nukkleus Inc. (NASDAQ:NUKK)’s share price rose 8.7% during mid-day trading on Monday . The company traded as high as $2.11 and last traded at $2.0650. Approximately 1,016,541 shares changed hands during trading, a decline of 54% from the average daily volume of 2,219,789 shares. The stock had previously closed at $1.90.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. Wall Street Zen raised Nukkleus from a “sell” rating to a “hold” rating in a research note on Sunday, November 23rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Nukkleus Price Performance

The stock has a market cap of $34.38 million, a P/E ratio of 0.13 and a beta of -6.76. The stock’s 50 day simple moving average is $3.21 and its two-hundred day simple moving average is $5.11.

Insiders Place Their Bets

In other news, major shareholder Sc Capital Ii Sponsor Llc purchased 255,000 shares of the business’s stock in a transaction dated Friday, November 28th. The shares were bought at an average cost of $10.00 per share, for a total transaction of $2,550,000.00. Following the completion of the acquisition, the insider directly owned 255,000 shares in the company, valued at approximately $2,550,000. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Anastasiia Kotaieva sold 75,000 shares of the company’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $4.09, for a total value of $306,750.00. Following the transaction, the insider directly owned 75,000 shares of the company’s stock, valued at $306,750. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 394,952 shares of company stock valued at $1,745,457. Company insiders own 7.90% of the company’s stock.

Institutional Investors Weigh In On Nukkleus

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC lifted its stake in Nukkleus by 193.7% in the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after acquiring an additional 82,252 shares in the last quarter. LPL Financial LLC bought a new position in shares of Nukkleus during the 4th quarter worth approximately $120,000. Engineers Gate Manager LP acquired a new stake in shares of Nukkleus in the fourth quarter valued at approximately $96,000. UBS Group AG lifted its position in shares of Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after purchasing an additional 15,223 shares in the last quarter. Finally, Ausdal Financial Partners Inc. bought a new stake in shares of Nukkleus in the third quarter worth $105,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.